Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67:7–30. https://doi.org/10.3322/caac.21387

Article  PubMed  Google Scholar 

Burbach JPM, den Harder AM, Intven M et al (2014) Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol 113:1–9. https://doi.org/10.1016/j.radonc.2014.08.035

Article  PubMed  Google Scholar 

Keller DS, Berho M, Perez RO et al (2020) The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol 17:414–429. https://doi.org/10.1038/s41575-020-0275-y

Article  PubMed  Google Scholar 

Gambacorta MA, Masciocchi C, Chiloiro G et al (2021) Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiother Oncol 154:154–160. https://doi.org/10.1016/j.radonc.2020.09.026

Article  CAS  PubMed  Google Scholar 

Habr-Gama A, Lynn PB, Jorge JMN et al (2016) Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum 59:264–269. https://doi.org/10.1097/DCR.0000000000000543

Article  PubMed  Google Scholar 

Chiloiro G, Meldolesi E, Giraffa M et al (2021) Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis. Clin Transl Radiat Oncol 28:1–9. https://doi.org/10.1016/j.ctro.2021.02.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bedin C, Crotti S, D’Angelo E et al (2020) Circulating biomarkers for response prediction of rectal cancer to neoadjuvant chemoradiotherapy. Curr Med Chem 27:4274–4294. https://doi.org/10.2174/0929867326666190507084839

Article  CAS  PubMed  Google Scholar 

Dayde D, Tanaka I, Jain R et al (2017) Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer. Int J Mol Sci. https://doi.org/10.3390/ijms18030573

Article  PubMed  PubMed Central  Google Scholar 

Horvat N, Veeraraghavan H, Khan M et al (2018) MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology 287:833–843. https://doi.org/10.1148/radiol.2018172300

Article  PubMed  Google Scholar 

Li Y, Liu W, Pei Q et al (2019) Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer. Cancer Med 8:7244–7252. https://doi.org/10.1002/cam4.2636

Article  PubMed  PubMed Central  Google Scholar 

Mazzei MA, Nardone V, Di Giacomo L et al (2018) The role of delta radiomics in gastric cancer. Quant Imaging Med Surg 8:719–721. https://doi.org/10.21037/qims.2018.07.08

Article  PubMed  PubMed Central  Google Scholar 

Boldrini L, Cusumano D, Chiloiro G et al (2019) Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach. Radiologia Medica 124:145–153. https://doi.org/10.1007/s11547-018-0951-y

Article  PubMed  Google Scholar 

Cusumano D, Boldrini L, Yadav P et al (2021) Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation. Physica Med 84:186–191. https://doi.org/10.1016/j.ejmp.2021.03.038

Article  Google Scholar 

Fave X, Zhang L, Yang J et al (2017) Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep 7:588. https://doi.org/10.1038/s41598-017-00665-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Timmeren JE, Leijenaar RTH, van Elmpt W et al (2017) Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. Radiother Oncol 123:363–369. https://doi.org/10.1016/j.radonc.2017.04.016

Article  PubMed  Google Scholar 

Bagher-Ebadian H, Siddiqui F, Liu C et al (2017) On the impact of smoothing and noise on robustness of CT and CBCT radiomics features for patients with head and neck cancers. Med Phys 44:1755–1770. https://doi.org/10.1002/mp.12188

Article  PubMed  Google Scholar 

Alahmari SS, Cherezov D, Goldgof D et al (2018) Delta radiomics improves pulmonary nodule malignancy prediction in lung cancer screening. IEEE Access 6:77796–77806. https://doi.org/10.1109/ACCESS.2018.2884126

Article  PubMed  PubMed Central  Google Scholar 

Cusumano D, Boldrini L, Dhont J et al (2021) Artificial intelligence in magnetic resonance guided radiotherapy: medical and physical considerations on state of art and future perspectives. Physica Med 85:175–191. https://doi.org/10.1016/j.ejmp.2021.05.010

Article  Google Scholar 

Fiorino C, Gumina C, Passoni P et al (2018) A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Radiother Oncol 128:564–568. https://doi.org/10.1016/j.radonc.2018.06.019

Article  PubMed  Google Scholar 

Broggi S, Passoni P, Gumina C et al (2020) Predicting pathological response after radio-chemotherapy for rectal cancer: impact of late oxaliplatin administration. Radiother Oncol 149:174–180. https://doi.org/10.1016/j.radonc.2020.05.019

Article  CAS  PubMed  Google Scholar 

Cusumano D, Boldrini L, Yadav P et al (2020) External validation of early regression index (ERITCP) as predictor of pathologic complete response in rectal cancer using magnetic resonance-guided radiation therapy. Int J Radiat Oncol Biol Phys 108:1347–1356. https://doi.org/10.1016/j.ijrobp.2020.07.2323

Article  PubMed  Google Scholar 

Fiorino C, Passoni P, Palmisano A et al (2019) Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index. Clin Transl Radiat Oncol 19:12–16. https://doi.org/10.1016/j.ctro.2019.07.001

Article  PubMed  PubMed Central  Google Scholar 

Chiloiro G, Cusumano D, Boldrini L et al (2022) THUNDER 2: theragnostic utilities for neoplastic diseases of the rectum by MRI guided radiotherapy. BMC Cancer 22:67. https://doi.org/10.1186/s12885-021-09158-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rödel C, Graeven U, Fietkau R et al (2015) Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 16:979–989. https://doi.org/10.1016/S1470-2045(15)00159-X

Article  CAS  PubMed  Google Scholar 

Valentini V, Gambacorta MA, Barbaro B et al (2016) International consensus guidelines on clinical target volume delineation in rectal cancer. Radiother Oncol 120:195–201. https://doi.org/10.1016/j.radonc.2016.07.017

Article  PubMed  Google Scholar 

Chiloiro G, Boldrini L, Meldolesi E et al (2019) MR-guided radiotherapy in rectal cancer: first clinical experience of an innovative technology. Clin Transl Radiat Oncol 18:80–86. https://doi.org/10.1016/j.ctro.2019.04.006

Article  PubMed  PubMed Central  Google Scholar 

Boldrini L, Placidi E, Dinapoli N et al (2018) Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: an in silico evaluation. Tech Innov Patient Support Radiat Oncol 6:5–10. https://doi.org/10.1016/j.tipsro.2018.02.002

Article  PubMed  PubMed Central  Google Scholar 

Chiloiro G, Cusumano D, de Franco P et al (2022) Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development. Radiologia Medica 127:11–20. https://doi.org/10.1007/s11547-021-01421-0

Article  PubMed  Google Scholar 

Suárez J, Vera R, Balén E et al (2008) Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 10:563–568. https://doi.org/10.1111/j.1463-1318.2007.01424.x

Article  PubMed  Google Scholar 

Mandard A-M, Dalibard F, Mandard J-C et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correl Cancer 73:2680–2686. https://doi.org/10.1002/1097-0142(19940601)73:11%3c2680::AID-CNCR2820731105%3e3.0.CO;2-C

Article  CAS  Google Scholar 

Parmar C, Grossmann P, Bussink J et al (2015) Machine Learning methods for Quantitative Radiomic Biomarkers. Sci Rep 5:13087. https://doi.org/10.1038/srep13087

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Rankine L, Green OL et al (2015) Characterization of the onboard imaging unit for the first clinical magnetic resonance image guided radiation therapy system. Med Phys 42:5828–5837. https://doi.org/10.1118/1.4930249

Article  PubMed  Google Scholar 

Fowler JF (2010) 21 years of biologically effective dose. Br J Radiol 83:554–568. https://doi.org/10.1259/bjr/31372149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 358:1291–1304. https://doi.org/10.1016/S0140-6736(01)06409-1

Glimelius B (2013) Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 19:8489–8501. https://doi.org/10.3748/wjg.v19.i46.8489

Article